Spots Global Cancer Trial Database for gvax
Every month we try and update this database with for gvax cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | NCT00116441 | Multiple Myelom... | Therapeutic Cel... | 18 Years - 70 Years | Cell Genesys | |
| Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma | NCT00024466 | Multiple Myelom... | GVAX Autologous tran... | 18 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer | NCT01696877 | Prostate Cancer... | degarelix aceta... Cyclophosphamid... GVAX | 21 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00089856 | Prostate Cancer | Immunotherapy w... Chemotherapy (T... | 18 Years - | Cell Genesys | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab | NCT02243371 | Previously Trea... | CRS-207 CRS-207 nivolumab GVAX CY | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | NCT00122005 | Prostate Cancer | GM-CSF gene tra... | 18 Years - | Providence Health & Services | |
| GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | NCT00122005 | Prostate Cancer | GM-CSF gene tra... | 18 Years - | Providence Health & Services | |
| Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer | NCT03190265 | Pancreatic Canc... | Cyclophosphamid... Nivolumab Ipilimumab GVAX Pancreas V... CRS-207 CRS-207 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia | NCT00116467 | Acute Myelogeno... | GVAX leukemia v... | 18 Years - 60 Years | Cell Genesys | |
| Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | NCT01510288 | Prostate Cancer | GVAX and ipilim... | 18 Years - 80 Years | Amsterdam UMC, location VUmc | |
| Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting | NCT02004262 | 2nd-line, 3rd-l... | GVAX Pancreas V... CRS-207 Chemotherapy cyclophosphamid... | 18 Years - | Aduro Biotech, Inc. | |
| Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia | NCT00116467 | Acute Myelogeno... | GVAX leukemia v... | 18 Years - 60 Years | Cell Genesys | |
| Pilot Study of GVAX in Colorectal Cancer Cells | NCT01952730 | Colorectal Canc... | GVAX | 18 Years - | Massachusetts General Hospital | |
| Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer | NCT03006302 | Metastatic Panc... | Epacadostat Pembrolizumab CRS-207 CY GVAX | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma | NCT01435499 | Melanoma | melanoma GVAX Cyclophosphamid... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine | NCT00140348 | Prostate Cancer | Immunotherapy a... | 18 Years - | Cell Genesys | |
| GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies | NCT00426205 | Myelodysplastic... Refractory Acut... Refractory CML ... | GM-CSF secretin... | 18 Years - | Dana-Farber Cancer Institute | |
| GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies | NCT00426205 | Myelodysplastic... Refractory Acut... Refractory CML ... | GM-CSF secretin... | 18 Years - | Dana-Farber Cancer Institute | |
| Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission | NCT03376477 | Multiple Myelom... | GM-CSF vaccine Lenalidomide Prevnar13 Placebo Prevnar... Placebo GM-CSF ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas | NCT03153410 | Pancreatic Canc... | Cyclophosphamid... GVAX Pembrolizumab IMC-CS4 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer | NCT01417000 | Metastatic Panc... | GVAX Pancreas CRS-207 Cyclophosphamid... | 18 Years - | Aduro Biotech, Inc. | |
| Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer | NCT00140400 | Prostate Cancer | Immunotherapy a... | 18 Years - | Cell Genesys | |
| Pilot Study of GVAX in Colorectal Cancer Cells | NCT01952730 | Colorectal Canc... | GVAX | 18 Years - | Massachusetts General Hospital | |
| Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma | NCT01435499 | Melanoma | melanoma GVAX Cyclophosphamid... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
